OMC
EW icon

Old Mission Capital’s Edwards Lifesciences EW Stock Holding History

Old Mission Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-29,199
Closed -$3.31M – 1091
2021
Q3 		$3.31M Buy
+29,199
New +$3.33M 0.13% 147
2021
Q2 		– Sell
-26,499
Closed -$2.22M – 1077
2021
Q1 		$2.22M Buy
+26,499
New +$2.24M 0.12% 203
2020
Q2 		– Sell
-13,566
Closed -$853K – 532
2020
Q1 		$853K Buy
+13,566
New +$978K 0.07% 149

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Old Mission Capital's EW Position: Q4 2021 in Review

Old Mission Capital sold out of Edwards Lifesciences (EW) in Q4 2021, closing a stake of 29,199 shares — an estimated $3.31M sold.

Old Mission Capital first reported a position in EW in Q1 2020 and held it in 3 quarters. The position peaked at $3.31M in Q3 2021. 1,319 funds tracked by Wall St. Rank hold EW as of Q4 2021.

  • Old Mission Capital reported no remaining Edwards Lifesciences position as of Q4 2021 after selling out during the quarter.
  • Old Mission Capital sold 29,199 Edwards Lifesciences shares in Q4 2021, an estimated $3.31M.
  • Old Mission Capital first reported a position in Edwards Lifesciences in Q1 2020 and held it in 3 quarters.
  • Old Mission Capital's Edwards Lifesciences position peaked at $3.31M in Q3 2021.
  • 1,319 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.

Based on Old Mission Capital's 13F filing for Q4 2021, filed 10 Feb 2022.